Skip to content

13F-HR filed by Fiera Capital (Europe) Ltd.

Fiera Capital (Europe) Ltd. filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-05, with 59 holding rows worth $138,618,000.

Accession
0001140361-14-040222
Filed
2014-11-05
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2014

A holdings report, 72 entries on the cover page, a total value of $138,618,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $138,618,000 with VALUE read as thousands by filing date, 13F file number 028-11574. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BAIDU INC SPON ADR REP A056752108ADR108,039$23,578,000thousands by filing date
ITAU UNIBANCO HLDG S A SPON ADR REP PFD465562106ADR1,477,445$20,588,000thousands by filing date
PETROLEO BRASILEIRO S A71654V101SP ADR NON VTG1,262,474$18,767,000thousands by filing date
BANCO BRADESCO S A059460303SP ADR PFD NEW519,589$7,422,000thousands by filing date
AMBEV SA SPONSORED ADR02319V103ADR1,103,575$7,245,000thousands by filing date
FOMENTO ECONOMICO MEXICANO S A SPON ADR UNITS344419106ADR65,724$6,056,000thousands by filing date
TAL ED GROUP SPONSORED ADS874080104ADR169,521$5,928,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR211,773$5,425,000thousands by filing date
GRUPO TELEVISA S A B40049J206SPON ADR REP ORD138,824$4,703,000thousands by filing date
BRF SA10552T107SPONSORED ADR186,336$4,430,000thousands by filing date
COMPANHIA BRASILEIRA DE DIST20440T201SPN ADR PFD CL A87,553$3,826,000thousands by filing date
GRUPO AVAL ACCIONES Y VALORE40053W101SPONSORED ADS277,850$3,775,000thousands by filing date
VALE S A91912E105SPONSORED ADS338,040$3,717,000thousands by filing date
VNET GROUP INC90138A103SPONSORED ADS A176,285$3,170,000thousands by filing date
GRANA Y MONTERO S A A38500P208SPONSORED ADR153,467$2,298,000thousands by filing date
CREDICORP LTDG2519Y109COM14,517$2,225,000thousands by filing date
CREDICORP LTDG2519Y108COM14,156$2,170,000thousands by filing date
COPA HOLDINGS SAP31076105CL A20,139$2,166,000thousands by filing date
ULTRAPAR PARTICIPACOES SA90400P101SP ADR REP COM89,622$1,892,000thousands by filing date
AVIANCA HLDGS SA05367G100SPON ADR REP PFD121,576$1,678,000thousands by filing date
Johnson & Johnson478160104COM6,718$718,000thousands by filing date
PETROLEO BRASILEIRO S A71654V408SPONSORED ADR39,657$562,000thousands by filing date
Pfizer Inc.717081103COM18,533$550,000thousands by filing date
COSAN LTDG25343107SHS A44,520$477,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS5,000$444,000thousands by filing date
Merck & Co.,Inc.58933Y105COM7,362$438,000thousands by filing date
Gilead Sciences,Inc.375558103COM4,020$428,000thousands by filing date
AbbVie,Inc.00287Y109COM5,332$309,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM2,020$247,000thousands by filing date
MYLAN INC628530107COM5,115$234,000thousands by filing date
Bristol-Myers Squibb Company110122108COM4,427$227,000thousands by filing date
MEDIVATION INC58501N101COM2,294$227,000thousands by filing date
Abbott Laboratories002824100COM5,110$213,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM1,197$188,000thousands by filing date
INSULET CORP COM45784P101Stock4,868$180,000thousands by filing date
MEDTRONIC INC585055106COM2,718$169,000thousands by filing date
CELGENE CORP151020104COM1,756$167,000thousands by filing date
ILLUMINA INC452327109COM948$156,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR2,700$152,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK35,200$150,000thousands by filing date
ALLERGAN INC184901025COM830$148,000thousands by filing date
BECTON DICKINSON & CO075887109COM1,050$120,000thousands by filing date
PHARMACYCLICS INC716933106COM937$110,000thousands by filing date
THERAVANCE BIOPHARMA INCG8807B106COM4,340$101,000thousands by filing date
Amgen Inc.031162100COM675$95,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM3,346$88,000thousands by filing date
Stryker Corporation863667101COM1,047$85,000thousands by filing date
BIOGEN INC COM09062X103Stock236$78,000thousands by filing date
THERAVANCE INC88338T104COMMON STOCK4,532$78,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM2,865$68,000thousands by filing date
Q74876Y101Stock973$54,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM664$48,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM4,081$45,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM612$41,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM1,380$39,000thousands by filing date
INCYTE CORP COM45337C102Stock769$38,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock105$38,000thousands by filing date
Boston Scientific Corporation101137107COM2,262$27,000thousands by filing date
MEDICINES CO584688105COM970$22,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-14-040222this filing2014-11-05acceptance time not in the bulk data set